About Us

About Sabre Technologies 

Sabre Technologies specializes in chlorine dioxide applications that eliminate and control biological and chemical contamination. Sabre’s significant history and numerous patents on chlorine dioxide generation and process technology provide the framework for unique solutions to many industries, including Oil & Gas, Environmental, Food & Agriculture, and Water Treatment. 

Sabre's technology and experts have provided unique and effective solutions to complex problems involving severe biological building contaminations, Emergency Response for biological and chemical incidents, Oil & Gas Well Stimulation and Water Treatment, and deliverable ClO₂ solutions for Legionella and waterborne pathogen control. Sabre has broad experience accompanied by a specialized and focused understanding of chlorine dioxide and the scope of its applications. 

Sabre's treatment and service quality have not only been demonstrated over decades in the oilfield, but on other platforms as well. After the 2001 anthrax attacks, Sabre was commissioned by the US Government to decontaminate all of the affected buildings. Under intense public and government scrutiny, the safety and efficacy of Sabre's technology and the expertise of Sabre employees led to an official acknowledgement by the National Academy of Sciences that Sabre provides the best method for large-scale decontamination. 

Sabre's newest fleet is comprised of GEN8 mobile generation systems. These units are the most advanced and integrated chlorine dioxide systems in the oilfield, with the versatility to treat a wide array of applications and demands. The system's high-capacity allows treatment of frac and produced fluid on-the-fly, as well as perform SabreStim™ well stimulations. The GEN8 was carefully developed using two decades of experience implementing chlorine dioxide in the oilfield, the best patented generation technology in the industry, and in-house teams of engineers, scientists and operators.  

 

Get In Touch

Please enter your name.

Please enter your email address.

Please enter your message.